Acme Formulation Profile
Key Indicators
- Authorised Capital ₹ 18.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 7.25 Cr
as on 15-11-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 115.72 Cr
as on 15-11-2024
- Satisfied Charges ₹ 202.58 Cr
as on 15-11-2024
- Revenue 26.02%
(FY 2023)
- Profit 146.38%
(FY 2023)
- Ebitda 79.09%
(FY 2023)
- Net Worth 5.58%
(FY 2023)
- Total Assets 2.98%
(FY 2023)
About Acme Formulation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 18.00 Cr and a paid-up capital of Rs 7.25 Cr.
The company currently has active open charges totaling ₹115.72 Cr. The company has closed loans amounting to ₹202.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Acme Formulation Private Limited India are Ginny Uppal as COMPANY SECRETARY and Viral Shah as Ceo. Viral Shah, Nikhilkumar Srivastava, Vikas Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230HP2004PTC027223
- Company No.
027223
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- LocationHimachal Pradesh, Himachal Pradesh
- Telephone
- Email Address
- Website
- Social Media
What products or services does Acme Formulation Private Limited offer?
Acme Formulation Private Limited offers a wide range of products and services, including Waste Management & Control Services, Waste Management Services, Packaging Solutions, Contract Packaging Services, Waste Management Consultants, Pharmaceutical Machines, Liquid Oral Manufacturing Plant, Construction Service, Pipeline Work Services, Pharmaceutical Machinery & Equipment.
Who are the key members and board of directors at Acme Formulation?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viral Shah  | Managing Director | 24-Jan-2007 | Current |
| Ginny Uppal | Company Secretary | 15-Oct-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhilkumar Srivastava | Director | 04-Oct-2021 | Current |
| Vikas Sharma | Whole-Time Director | 29-Jul-2020 | Current |
| Aswin Vikram | Director | 04-Oct-2021 | Current |
Financial Performance and Corporate Structure Insights of Acme Formulation.
Acme Formulation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.02% increase. The company also saw a substantial improvement in profitability, with a 146.38% increase in profit. The company's net worth moved up by a moderate rise of 5.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acme Formulation?
In 2023, Acme Formulation had a promoter holding of 40.66% and a public holding of 59.34%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Immacule Lifesciences Private LimitedActive 14 years 3 monthsViral Shah, Vikas Sharma and 2 more are mutual person
Acme Generics Private LimitedActive 3 years 4 monthsViral Shah, Vikas Sharma and 1 more are mutual person
Nuvama Wealth Management LimitedActive 31 years 4 monthsNikhilkumar Srivastava and Aswin Vikram are mutual person
- Nuvama And Cushman & Wakefield Management Private LimitedActive 1 year 3 months
Nikhilkumar Srivastava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 06 Aug 2021 | ₹50.72 Cr | Open |
Hdfc Bank Limited Creation Date: 17 Jan 2020 | ₹8.50 Cr | Open |
Hdfc Bank Limited Creation Date: 17 Jan 2020 | ₹26.00 Cr | Open |
How Many Employees Work at Acme Formulation?
Acme Formulation has a workforce of 601 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acme Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
